Koyfin Home > Directory > Health Care > Achillion Pharmaceuticals > Price / Earnings (ltm)

Achillion Pharmaceuticals Price / Earnings (ltm) Chart (ACHN)

Achillion Pharmaceuticals annual/quarterly Price / Earnings (ltm) from 2016 to 2016. The price-earnings ratio (P/E ratio) is the ratio for valuing a company that measures its current share price relative to its consensus EPS estimate of the next twelve months (NTM). The price-earnings ratio is also sometimes known as the price multiple or the earnings multiple.
  • Achillion Pharmaceuticals Price / Earnings (ltm) for the quarter ending November 11, 2016 was 123.87 a -7.12% decrease of -8.82 year over year
  • Achillion Pharmaceuticals Price / Earnings (ltm) for the last 12 months ending November 11, 2016 was 123.87 a -7.12% decrease of -8.82 year over year
  • Achillion Pharmaceuticals Annual Price / Earnings (ltm) for 2016 was 123.87 a -2.65% decrease of -3.28 from 2015
  • Achillion Pharmaceuticals Annual Price / Earnings (ltm) for 2016 was 127.15 a -1.29% decrease of -1.64 from 2015
  • Achillion Pharmaceuticals Annual Price / Earnings (ltm) for 2016 was 128.79 a -3.03% decrease of -3.90 from 2015
Other Valuation Metrics:
  • Achillion Pharmaceuticals Market Cap for the quarter ending March 03, 2018 was $512m a -22.67% decrease of -116m year over year
  • Achillion Pharmaceuticals Price / Book for the quarter ending March 03, 2018 was 1.58 a -4.12% decrease of -0.06 year over year
  • Achillion Pharmaceuticals Enterprise Value for the quarter ending March 03, 2018 was $212m a -17.56% decrease of -37m year over year
View Chart On Koyfin

Quarterly ACHN Price / Earnings (ltm) Data

11/2016123.87
11/2016127.15
10/2016128.79
10/2016132.69
10/2016133.92
10/2016137.40
10/2016137.81
10/2016140.27
10/2016143.14
10/2016143.76

Annual ACHN Price / Earnings (ltm) Data

2016123.87
2016127.15
2016128.79
2016132.69
2016133.92
2016137.40
2016137.81
2016140.27
2016143.14
2016143.76